What is Union Biometrica?
Founded in 1998, Union Biometrica is a specialized technology firm focused on Large Particle Flow Cytometry. The company designs and manufactures advanced flow cytometers, including the COPAS and BioSorter systems, engineered to handle large or delicate biological specimens that are incompatible with traditional cytometry methods. These instruments facilitate automated analysis and gentle sorting of diverse samples such as stem cells, cell clusters, and model organisms like zebrafish embryos and C. elegans. Union Biometrica's innovative solutions empower researchers in biotechnology and life sciences across North America and Europe to achieve higher throughput, improved sensitivity, enhanced quantification, and greater reproducibility in their experiments.
How much funding has Union Biometrica raised?
Union Biometrica has raised a total of $816K across 2 funding rounds:
Debt
$350K
Debt
$466K
Debt (2020): $350K with participation from PPP
Debt (2021): $466K led by PPP
What's next for Union Biometrica?
The substantial enterprise-level capital infusion positions Union Biometrica for strategic growth and further technological development. This backing is expected to fuel advancements in their Large Particle Flow Cytometry technology, potentially expanding their product offerings and market reach. The company's focus on specialized research tools for the life sciences indicates a trajectory towards solidifying its niche leadership and supporting critical scientific discoveries.
See full Union Biometrica company page
